Comparação da hemossiderina com o tecnécio-99 na identificação do linfonodo sentinela do câncer de mama. /Paulo Henrique Diógenes Vasques

Vasques, Paulo Henrique Diógenes.
Fortaleza; s.n; 2016. 140 p. ilus, tab.
Tesis en Portugués | LILACS | ID: biblio-972056

Documentos relacionados

  1. A Pilot Study Evaluating the Effects of Magtrace® for Sentinel Node Biopsy in Breast Cancer Patients Regarding Care Process Optimization, Reimbursement, Surgical Time, and Patient Comfort Compared With Standard Technetium<sup>99</sup>.
  2. Identification of the sentinel lymph node using hemosiderin in locally advanced breast cancer.
  3. Identification of the sentinel lymph node using hemosiderin in locally advanced breast cancer
  4. Evaluation of Dual Dye Technique for Sentinel Lymph Node Biopsy in Breast Cancer: Two-Arm Open-Label Parallel Design Non-Inferiority Randomized Controlled Trial.
  5. [Domestic system for fluorescent diagnostics in breast cancer: pros and cons].
  6. Sentinel Lymph Node Mapping in Breast Cancer Patients Through Fluorescent Imaging Using Indocyanine Green: The INFLUENCE Trial.
  7. Indocyanine green combined with methylene blue versus methylene blue alone for sentinel lymph node biopsy in breast cancer: a retrospective study.
  8. Sentinel lymph node nonvisualization after intratumoral radioisotope tracer injection in breast cancer is not associated with a higher nodal metastasis rate or worse outcomes.
  9. Sentinel lymph node biopsy for breast cancer during pregnancy: A comprehensive update.
  10. Deciphering breast cancer: from biology to the clinic.